JUN 18, 2019 11:00 AM PDT

Writing the NIH Research (R01) grant: Strategies for Success

Sponsored by: Leica Microsystems
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Consultant, Medcom Consulting
    Biography
      Dr. Christopher Dant is a PhD-trained investigator and consultant in the biomedical field. Early in his career, he was an investigator at high-performance laboratories at Indiana University, University of Michigan, and Stanford Medical School. Early in his postgraduate career, he apprenticed with a Senior Editor at JAMA and became as a Principal Scientist at NASA's Life Sciences Division and Department of Energy, where he worked with investigators to obtain federal grants and to write successful manuscripts for peer-reviewed journals. Until this past year, Dr. Dant served on the faculty at Dartmouth's Geisel School of Medicine and Norris Cotton Cancer Center as a lecturer and investigator for PIs, Postdoctoral Fellows, and Students to successfully expand NIH grant portfolios. Before coming to Dartmouth, Dant was the Director of Medical Publications at Genentech and earlier served as a faculty instructor at the Stanford Medical School and as a grant editor/writer at a large Stanford Medical laboratory. He lectures and consults widely in academia and Industry on manuscript writing, NIH and NSF career and research grants, and basic scientific writing skills for scientists. His business, MEDCOM Consulting, serves academic clients to review and write NIH Grants, as well as peer-reviewed manuscripts (medcomconsul@gmail.com).

    Abstract
    DATE:   June 18, 2019
    TIME:    11:00am PDT, 2:00pm EDT
     
     
    With highly competitive NIH budgets and ever-increasing restrictions on federal spending, getting noticed and winning an NIH R grant is far more difficult and highly competitive than it has ever been. To be competitive today, new and inexperienced grant writers must learn the essentials of strong grantsmanship that is rarely taught today in academia. 
     
    In 2018, the overall success rate for NIH R01 grants was just 20%, with some Institutes approving only 10% of submitted applications. This means that NIH-wide, nearly 8 out of 10 R01 application submissions are rejected. If you want to be one of the PIs that receives research grant funding, you must be able to write your grant so that it prevails over the five review criteria which generates your overall impact score. 
     
    Many investigators, especially new investigators, don’t know how to write a winning grant or understand what pitfalls to avoid. Writing a winning grant proposal that gets noticed by reviewers requires that investigators produce a highly polished, cohesive grant that really knocks it out of the park for its significance, innovation, and approach while showing that it will have a major impact on their field. In this webinar, Dr. Dant will provide you with details of what reviewers want and don’t want to see in your R01 grant proposal. Ultimately, you’ll learn how to write your next R01 grant in a way that will get reviewer’s attention and influence them to approve and fund your research proposal.
     
    We present a systematic approach to writing a winning grant by showing some common mistakes investigators often make in writing their grant that causes it to immediately fail. We will discuss the optimum grant organization, aesthetics, and aspects of writing that are also vital to a competitive presentation. We present advice on grant writing that is taken from the NIH as well as from faculty who have written successful grants and served as peer reviewers. 
     
    Learning Objectives:
    • Learn the fundamentals of National Institutes of Health (NIH) Research (R) grants that fund most of the biomedical research in the United States.
    • Learn a strategy for writing a successfully funded NIH R01 grant proposal proven by leading PIs and NIH peer reviewers.
    Join us on June 18th at 11:00am PDT, 2:00pm EDT for this 90 minute broadcast featuring a live interactive Question and Answer session after the presentation.
     
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
     

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources
    Attendees
    • See more